Increased agonistic autoantibodies against AT1R (AT1-AA) in preeclampsia [59,60] also contribute to AT1R activation, whereas AT1-AA blockade was shown to reduce preeclamptic symptoms in rats [61]. Here, AGTR1 is linked to preeclampsia.